BioCentury | Aug 11, 2017
Regulation

Foundation for inclusion

...care includes the off-label use of steroids, Soliris eculizumab from Alexion Pharmaceuticals Inc. or CellCept mycophenolate mofetil...
...that is approved to treat paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). CellCept...
BioCentury | Jun 16, 2017
Clinical News

Aurinia starts Phase III AURORA trial of voclosporin for lupus nephritis

...enroll about 320 patients to receive twice-daily 23.7 mg voclosporin plus standard of care (SOC) mycophenolate mofetil...
BioCentury | Apr 13, 2017
Clinical News

Voclosporin regulatory update

...which will enroll about 320 patients on background corticosteroids to evaluate voclosporin or placebo plus mycophenolate mofetil...
BioCentury | Apr 7, 2017
Company News

Aurinia rises as regulators clarify path for voclosporin

...AURORA study this quarter. The 52-week trial will evaluate response rates in 320 patients receiving mycophenolate mofetil...
BioCentury | Mar 10, 2017
Clinical News

Voclosporin: Additional Ph IIb AURA-LV data

...nephritis showed that twice-daily 23.7 and 39.5 mg oral voclosporin plus standard of care (SOC) mycophenolate mofetil...
BioCentury | Mar 2, 2017
Clinical News

Aurinia bounces on latest lupus nephritis readout

...high dose vs. 48% for placebo. In addition to placebo or voclosporin, patients received CellCept mycophenolate mofetil...
BioCentury | Dec 2, 2016
Product Development

New day for nephrons

...of steroids. AURA-LV tested 23.7 or 39.5 mg voclosporin twice daily. SOC consisted of CellCept mycophenolate mofetil...
...irritability, weight gain and sleep disturbance. Dooley added that the standard regimen involving Roche ’s CellCept...
...AURORA trial will test 23.7 mg voclosporin twice daily vs. placebo on a background of CellCept...
BioCentury | Aug 22, 2016
Clinical News

Luveniq voclosporin: Phase IIb data

...active lupus nephritis showed that twice-daily 23.7 mg oral voclosporin plus standard of care (SOC) mycophenolate mofetil...
BioCentury | Aug 15, 2016
Clinical News

Aurinia sinks on Phase IIb lupus nephritis results

...received 23.7 or 39.5 mg voclosporin or placebo twice daily in combination with corticosteroids and mycophenolate mofetil...
BioCentury | Feb 22, 2016
Clinical News

Luveniq voclosporin: Clinical trial preliminary data

...nephritis in the open-label, Malaysian AURION trial showed that twice-daily 23.7 mg oral voclosporin plus mycophenolate mofetil...
Items per page:
1 - 10 of 171